Left Ventricular Hypertrophy. Liebson PR. Curr Treat Options Cardiovasc Med. 1999 Oct;1(3):219-230. doi: 10.1007/s11936-999-0038-0. PMID: 11096487
Goals and guidelines for treating hypertension in a patient with heart failure. Lee DS, Vasan RS. Curr Treat Options Cardiovasc Med. 2006 Aug;8(4):334-44. doi: 10.1007/s11936-006-0054-2. PMID: 17038273
Comorbid CAD and ventricular hypertrophy compromise the perfusion of myocardial tissue at subcritical stenosis of epicardial coronaries. Abbas E. Egypt Heart J. 2019 Aug 05;71(1):3. doi: 10.1186/s43044-019-0003-5. PMID: 31659531
Ultimate phases of hypertensive heart disease and stressed heart morphology by conventional and novel cardiac imaging. Yalçin F, Yalçin H, Abraham MR, Abraham TP. Am J Cardiovasc Dis. 2021 Oct 25;11(5):628-634. eCollection 2021. PMID: 34849295
Basal Septal Hypertrophy as the Early Imaging Biomarker for Adaptive Phase of Remodeling Prior to Heart Failure. Yalçin F, Yalçin H, Küçükler N, Arslan S, Akkuş O, Kurtul A, Abraham MR. J Clin Med. 2021 Dec 24;11(1). doi: 10.3390/jcm11010075. PMID: 35011816
Syndrome X. Al Suwaidi J, Lerman A. Curr Treat Options Cardiovasc Med. 2000 Feb;2(1):73-82. doi: 10.1007/s11936-000-0030-1. PMID: 11096512
Diastolic Dysfunction. Murphy SW. Curr Treat Options Cardiovasc Med. 2004 Feb;6(1):61-68. doi: 10.1007/s11936-004-0015-6. PMID: 15023285